202 related articles for article (PubMed ID: 4567562)
1. Methotrexate in the treatment of psoriasis.
Med Lett Drugs Ther; 1972 Jun; 14(12):41-2. PubMed ID: 4567562
[No Abstract] [Full Text] [Related]
2. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
Nyfors A
Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
[No Abstract] [Full Text] [Related]
3. Toxicity of low dose methotrexate in rheumatoid arthritis.
Weinblatt ME
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775
[TBL] [Abstract][Full Text] [Related]
4. Hazards of prolonged low-dose methotrexate therapy.
Bender AS
Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468
[No Abstract] [Full Text] [Related]
5. Use of methotrexate in psoriasis.
Roenigk HH; Maibach HI; Weinstein GD
Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
[No Abstract] [Full Text] [Related]
6. Methotrexate for psoriasis.
Rees RB; Bennett JH; Maibach HI; Arnold HL
Arch Dermatol; 1967 Jan; 95(1):2-11. PubMed ID: 6066717
[No Abstract] [Full Text] [Related]
7. [Dynamics of some indices of interstitial metabolism in patients with psoriasis during treatment with methotrexate].
Smelov NS; Lashmanova AP; Nikitina LV; Fedorovskaia RF; Makashev TK
Vestn Dermatol Venerol; 1975 Nov; (11):8-13. PubMed ID: 1220384
[No Abstract] [Full Text] [Related]
8. [Methotrexate in dermatology: current aspects].
Plantin P; Saraux A; Guillet G
Ann Dermatol Venereol; 1989; 116(2):109-15. PubMed ID: 2660705
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate in psoriasis with and without leucovorin: effect of different dosage schedules on acute liver toxicity.
Zachariae H; Bjerring P
Acta Derm Venereol; 1982; 62(5):446-8. PubMed ID: 6183902
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Palmer HM
Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
[No Abstract] [Full Text] [Related]
11. Liver injury associated with methotrexate therapy for psoriasis.
Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
[No Abstract] [Full Text] [Related]
12. [Oral methotrexate therapy: pro and con].
Zachariae H
Hautarzt; 1985 Jan; 36(1):10-2. PubMed ID: 3972575
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate in psoriasis: revised guidelines.
Roenigk HH; Auerbach R; Maibach HI; Weinstein GD
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):145-56. PubMed ID: 3042816
[No Abstract] [Full Text] [Related]
14. [Experience with methotrexate in the management of psoriasis].
Mazzi R
Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
[No Abstract] [Full Text] [Related]
15. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
16. Effects of methotrexate on the liver in psoriasis.
Reese LT; Grisham JW; Aach RD; Eisen AZ
J Invest Dermatol; 1974 Jun; 62(6):597-602. PubMed ID: 4835782
[No Abstract] [Full Text] [Related]
17. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
18. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
[No Abstract] [Full Text] [Related]
20. Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
Chan H; Evans WE; Pratt CB
Cancer Treat Rep; 1977 Aug; 61(5):797-804. PubMed ID: 19151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
